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The reduction of unwarranted clinical variation is 
a common goal of healthcare systems worldwide. 
However, the process of developing and implementing 
variation reducing interventions as a quality 
improvement process is often overlooked and performed 
sub-optimally within healthcare organizations. This gap 
in practice is mirrored by a gap in existing research. 
The development of a clinical variation specific 
prescriptive model will assist with the identification, 
development and application of healthcare specific 
variation reducing initiatives. Such a model should 
complement the existing plan, do, study, act quality 
(PDSA) improvement methodology and respect the 
learning health systems (LHS) learning cycle.  
Development through the lens of the quadruple aim 
of healthcare will ensure that the focus remains true to 
the core values of clinical organizations. 
Addressing unwarranted clinical variation is a 
complex task, however. With organizational support, 
the utilization of collaborative methodologies and the 
leveraging of available digital health technologies, 
healthcare organizations are provided the greatest 
opportunity for the reduction of unwarranted clinical 
variation and the optimization of healthcare outcomes. 
1. Introduction  
The reduction of unwarranted clinical variation is a 
common goal of healthcare systems worldwide. While 
not all clinical variation is negative, and instead may 
facilitate beneficial change, variation is unwarranted 
when it is not justified by clinical imperatives, patient 
needs/preferences, or innovation. 
The reduction of unwarranted clinical variation 
may provide benefits that satisfy the quadruple aim of 
healthcare: to improve patient care, population health, 
cost of care, and clinician experience [1, 2].  
Addressing unwarranted clinical variation is a high 
priority complex task involving multiple elements with 
 
1 Electronic health record (EHR) & electronic medical record (EMR) 
may be used interchangeably and will be referred to as EMR 
throughout this paper. 
intricate interactions occurring between these 
components. Trade-offs often exist between the 
potentially competing elements of cost, quality, 
population health, clinicians, and patients. How to best 
identify, understand and address these trade-offs is an 
area that deserves additional attention as often the 
improvement of one aspect may be detrimental to 
another. For example, reduced costs via reductions in 
tests/drugs may have an adverse effect on patient 
outcomes. 
Clinical variation is often addressed by healthcare 
organizations with the standardization of clinical 
practice via quality improvement (QI) initiatives, 
ranging from process control (guidelines and pathways) 
to design development efforts (systems) [3, 4]. 
Electronic medical/health record (EMR/EHR1) 
systems provide organizations the opportunity to 
identify variation. Once identified, they can implement 
variation reducing QI initiatives by utilizing the ever-
increasing number of functions and features available in 
digital health systems. While this has been achieved 
with limited success ad-hoc, identifying the low-level 
details required to effectively select and implement 
unwarranted clinical variation reduction QI initiatives is 
a priority [5-7]. This work is predicated by literature 
review undertaken by the authors examining the impact 
of EMRs on variation in clinical care processes in 
hospital settings [6]. 
The objective of this paper is to introduce a model 
beneficial to healthcare organizations developing or 
implementing unwarranted clinical variation initiatives.  
2. Theoretical framework 
The healthcare sector has adopted numerous QI 
methodologies from clinical audit, Lean/Six sigma, plan 
do study/check act (PDSA/PDCA), process mapping, 
statistical process control, total quality management 
(TQM), root cause analysis and beyond with varying 
levels of success [8-10]. The majority of which center 
around a formal structure of continued iterative 
development undertaken by an organization. 





These quality improvement cycles often have 
similar stages of planning, doing/implementing, 
measuring/studying and act/sustaining improvements 
within their models [9, 11]. Perhaps the best-known 
methodology is PDSA.  
PDSA is a simple framework which has the 
advantage of being able to support many lower-level 
complex approaches such as organizational, social 
interventions to more technical computational based 
process modelling such CRISP-DM [12]. 
The PDSA cycle’s origins began with the Shewhart 
and later the Deming cycles and remains among the 
leading QI components worldwide [8, 13-15]. While the 
PDSA cycle is easily understood and applicable to most 
industries, applying this normative model to the real-
world task of addressing a specific instance of clinical 
variation is not easily achieved.  
To this end, a model that specifically address the 
requirements of the clinical variation reduction process 
has been developed to complement the existing PDSA 
methodology and the requirements of a learning health 
system (LHS) (Figure 1). 
 
Figure 1: Unwarranted clinical variation reduction process  
 
 
2.1 Variation identification  
(Figure 1-I) 
The identification of unwarranted clinical variation 
is an intricate task as it involves differentiating the 
clinical practice of clinicians with the intervention (such 
as the guidelines/pathway) from those outcomes 
associated with the intervention, along with the clinician 
use of the intervention. This may be best achieved 
through the lens of the quadruple aim of healthcare [1].  
By assessing outcomes and processes against the 
quadruple aim criteria, deficits and variations within the 
existing system are easily identifiable, thus minimizing 
unjustified differences between healthcare processes or 
outcomes when compared to peers, or to a gold standard 
is the ultimate goal [16]. 
 
Information technology (IT) advancements, digital 
health, and the use of clinical information systems (CIS) 
and EMRs have transformed clinical monitoring 
practices and provided the ability to more easily identify 
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and demonstrate elements of clinical variation (often in 
real-time). This may be achieved with the use of alerts, 
clinical decision support systems (CDSS), dashboard 
summaries, and big data analytics [17-19]. 
Traditional methods of variation identification 
should continue to be utilized in conjunction with digital 
based techniques. These may include anecdotal 
evidence from expert stakeholders, bedside 
reviews/rounds, financial analysis, clinician surveys, 
peak organization/network evidence and trend analysis 
such as statistical process control charts [20, 21]. 
 
2.2 Process input factors  
(Figure 1-II) 
Once the targeted aspect of clinical variation has 
been identified, the process of input factors discovery 
may commence. These factors may be supply-side with 
the clinician, demand-side factors from the 
consumer/patient or contextual environmental factors 
[22]: 
• Clinician factors (supply-side): expertise, 
training and experience, preference, practice style. 
• Consumer factors (demand-side): case 
complexity, consumer preference, social determinants 
of health.  
• Environmental factors (context): local 
guidelines, available resources, hospital casemix. 
 
In addition to affecting clinical practice in isolation, 
these individual factors may combine to influence 
clinical variation as a collective [22]. Determining the 
appropriate (or allowable) degree of variation for any 
specific clinical practice is a task typically undertaken at 
a local hospital or health service level to ensure that any 
specific district conditions are accounted for.  
That said, it is essential that the element of 
unwarranted clinical variation to be addressed meets 
some fundamental entry criteria. The variation should 
be deemed unwarranted, should align with an area of 
value for the organization (often cost linked), align with 
clinician goals, and be measurable/demonstrable both 
before and after any variation reduction changes are 
implemented [23].  
The healthcare organization must decide if 
addressing the factors involved in the unwarranted 
variation is within current organizational capacity. For 
example, should the factors involved be predominately 
consumer/patient, an organization may choose to 
develop a consumer-based education and training 
program, or develop consumer targeted infrastructure 
such as a patient portal. Alternatively, the organization 
may deem consumer factors as outside of their control, 
not financially viable or simply not aligned with core 
goals and instead elect to abandon this issue and with 
the use of the “Not viable” feedback loop, adjust and 
select another area of variation with a higher priority to 
address (Figure 1). 
Data collection/synthesis  
Data collection and synthesis is undertaken with 
data collected from a variety of means and systems. IT 
advancements have made improvements in the 
availability, collection, and manipulation of these 
data, often allowing near real-time analysis of key 
performance indicators via electronic dashboards and 
summaries.  
These include: 
- IT systems, inc. EMR, CIS, payroll, billing etc. 
- Key performance indicators (KPIs) 
- Meetings/ discussions 
- Surveys/polls, patient reported experience/outcome 
measures (PREMs & PROMs) 
- Anecdotal evidence 
Degree/type of variation  
Process input factor determination is also 
influenced by the type of variation that is identified, this 
may be variation from a level/standard, or variation 
around a level/standard.  
Variation from a level may be clinician adherence 
to an existing health service guideline, such as how 
closely the clinician adheres to the guidelines of practice 
or whether clinicians are meeting gold standard best 
practice guidelines.  
Variation around a level refers to the difference in 
practice outcomes after implementing a clinical 
guideline. This may be the implementation of a new 
best-practice guideline or existing guideline revisions.  
There are occasions where both are addressed with a 
single intervention. EMRs may be introduced to both 
implement a standard of care and achieve greater 
consistency in clinical practice [24]. 
2.3 Team development  
(Figure 1-III) 
The core team responsible for the development of 
the solution was comprised of a multi-disciplinary group 
of resources with representation from all relevant 
disciplines including practitioner/clinicians, champions, 
management, administration, financial, IT, analytics 
and potentially consumer/patients, working with a 
commitment to the quality improvement initiative [25].  
With a bottom-up approach and a wide variety of 
stakeholders from all levels of the organization, the 
team’s understanding, concerns and solution 
development will be enhanced through a comprehensive 
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understanding of the issues from multiple perspectives 
[23].  
Potential core team members include: 
• Administration – providing administrative 
and project management and support activities. 
• Practitioners – active clinicians who are 
providing the healthcare service, doctors, nurses, 
allied health etc. 
• Champions – a leading clinician from the 
field with a thorough understanding of the issue and 
the solution who is able to convey the message to 
colleagues. 
• Management – representatives of 
organizational management, operations 
management department head, chief information 
officer (CIO), chief clinical information officer (CCIO) 
etc. 
• Analytics – data analytics representation for 
data set analysis and requirements. 
Non-core members include: 
• IT – technical representation offering advice 
throughout the project lifecycle. 
• Finance – a member of the 
finance/accounting team able to understand the 
parameters of the work. 
• Consumers – as required, consumer 
representatives to provide insight into the patient 
perspective of proposed solutions. 
2.4 Solution development/implementation 
(Figure 1-IV) 
The intervention developed may include pillars of 
technical, change management, practice and underlying 
clinical theory and should be targeted to the process 
input factor(s) identified earlier in the process. 
 







The technical dimension involves identifying a 
system design that can help achieve the right level of 
variation (i.e. through the guidance it provides to users 
or the constraints or controls that it enforces). Technical 
priorities involved in the development of an intervention 
include access to adequate resources (including 
technical staff, infrastructure, and information) as well 
as clinician access for testing and development. 
To address this dimension, health services should 
seek to use an appropriately designed core health system 
that can provide the ability for continuation of patient 
care across the entire patent journey not just at a point 
in time. The technical system should also allow for 
adequate local customization to meet the requirements 
of the individual department, facility, or health service. 
This may include the need for local resources to provide 
development and customization. 
Change management  
The change management process.is critical to the 
success of an intervention. A clear vision and 
communication strategy is key to ensuring the alignment 
of all stakeholders. This includes stakeholder education 
and training, ongoing support and the measurement and 
monitoring of performance[26]. 
There is potential that the use of an intervention 
invokes behavioral and cultural change which takes both 
time and effort to achieve and maintain within any 
organization. 
Practice 
An intervention used by clinicians may be 
influenced by the clinicians’ level of knowledge, skill 
set or style of practice. Monitoring of the frontline 
clinical practice may identify any issues with clinician 
use (or avoidance of use) of the intervention. 
Underlying clinical theory 
Variation-reducing interventions should be based 
on underlying clinical theory – a clinically-defensible 
rationale for why the reduction in variation is 
appropriate. One approach to identifying the appropriate 
theory is to examine the guidelines, standards, care 
plans, or treatment plans that are best practice or 
industry standard in that domain. These are often 
developed by peak bodies and customized for local 
conditions. While these documents do not always 
explicate their underlying theory, it can often be 
uncovered through analyzing their composition and 
exploring their background materials. 
There are numerous ways available to modify the 
behavior and clinical workflow in order to reduce 
unwarranted clinical variation, via process control 
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efforts (e.g., clinical guidelines and pathways), and 
process design and development efforts [3, 4].  
This may be achieved via clinician training, 
guidelines/standards or certification through peak 
organizations, knowledgebases, masterclasses, and the 
provision of accessible information, or via system 
access controls forcing or limiting what is allowable by 
the clinician within the CIS/EMR (e.g. ordering, access, 
scheduling etc.). 
2.5 Outcome monitoring and review  
(Figure 1-V) 
The outcome monitoring and review element of the 
model has a dual role, providing an ongoing monitoring 
function as well as a feedback loop for solution 
adjustment. Ongoing periodic monitoring, reporting and 
review of clinical outcomes is essential to ensure that 
variation is minimized in the long-term.  
Outcome monitoring and review also provides a 
feedback function as new information comes to light 
while moving through the model. The viability and 
appropriateness of the solution may be constantly 
monitored and potentially adjusted.  
2.6 Solution adjustment  
(Figure 1-VI) 
The model cycle is closed with solution adjustment 
and revision. This may include redefining target 
outcomes, modifications to element(s) of the solution in 
any of the pillar(s) of technical, change management, 
practice, and underlying clinical theory, from minor 
refinements through to the development of completely 
new interventions.  
2.7 Organizational enablement (LHS) 
(Figure 1-VII) 
In order for a sustained level of success for 
organizational QI initiatives, an ethos of continued 
improvement needs to underpin the healthcare 
organizational structure. Learning health systems (LHS) 
have been developed around the core values of person-
focused, privacy, inclusiveness, transparency, 
accessibility, adaptability, governance, cooperative and 
participatory leadership, scientific integrity and value 
[27]. A long-term committed approach is required to 
position/reposition a healthcare organization as an LHS. 
The PDSA cycle should be considered within the 
greater LHS context and within the learning cycle 
(Figure 1). Compatibility between the PDSA QI cycle 
and the LHS learning cycle has been previously 
identified with both cycles containing complementary 
components and goals [28]. The learning cycle 
comprises similar elements of data gathering/analysis, 
feedback and implementing change and scale [29]. 
The stewardship and governance of LHSs is a task 
that becomes more difficult as systems scale to national 
or international levels involving various parties with 
fundamental differences in legal and ethical positions. 
Data considerations including sources, collection, 
standards, formats, quality, interoperability, security 
and storage, privacy and policies are all factors that the 
LHS my need to address [30]. 
These systems bring with them a change in 
demands for real-time information and opportunities to 
utilize technologies such as EMRs to disseminate 
clinical knowledge at a more rapid rate than the existing 
peer-reviewed journal articles process. 
4. Limitations and future research  
The LHS, and unwarranted clinical variation 
reduction process models revolve around the ability of 
the organization to develop solutions iteratively. This 
may not be the case when developing interventions 
within the real-world of healthcare budget cycles which 
are often underpinned with time-limited specific 
funding. Funding via periodic budgets, grants, 
sponsorships etc. makes the implementation of any 
solution potentially a one-off task [31]. In these cases, 
the iteration of a solution design may be replaced with 
the development of lessons learned to be utilized in 
future innovations. 
As the proposed model is multifaceted, 
identification of and control for, local variables may be 
required. 
This research is focused on the healthcare and 
clinical informatics setting, which would be beneficial 
to extend to other industries. There are potentially 
additional learnings around quality improvement that 
may be observed from other industries that can be 
applied back to the healthcare realm. 
Further validation both conceptually and 
empirically is to be undertaken as the next phase of this 
research.  
While there has been some pivotal work undertaken 
exploring clinical practice variation, continued research 
on these variation reducing initiatives is essential to 
ensure the most effective implementation and utilization 
of these systems [32, 33]. 
5. Conclusion 
Healthcare organizations attempting to address 
unwarranted clinical variation face a complex task, 
filled with potential trade-offs between separate and 
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often competing elements of the quadruple aim of 
healthcare, to improve patient care, population health, 
cost of care, and clinician experience. To date, most 
organizations have focused on meeting one or two of the 
quadruple aims, typically cost/efficiency and/or patient 
care outcomes [6].  
By striving to become learning organizations and 
closing the loop with consistent outcome monitoring 
and adjustment (Figure 1), combined with the latest 
digital health technologies and collaborative 
methodologies, healthcare organizations stand the 
greatest chance to reduce unwarranted clinical variation 
and optimize healthcare outcomes. 
7. Acknowledgements  
This research was funded via an Australian 
Research Council Linkage Projects grant 
(LP170101154). 
 
6. References  
[1] R. Sikka, J. M. Morath, and L. Leape, "The quadruple 
aim: care, health, cost and meaning in work," Editorial 
2015. 
[2] D. M. Berwick, T. W. Nolan, and J. Whittington, "The 
triple aim: care, health, and cost," (in eng), Health Aff 
(Millwood), vol. 27, no. 3, pp. 759-69, May-Jun 2008, 
doi: 10.1377/hlthaff.27.3.759. 
[3] C. P. McLaughlin, "Why variation reduction is not 
everything: a new paradigm for service operations," 
International Journal of Service Industry Management, 
1996. 
[4] C. McLaughlin and S. Johnson, "Inherent variability in 
service operations: identification, measurement and 
implications," Services Management: New Directions 
and Perspectives, Cassell, London, pp. 226-9, 1995. 
[5] L. M. Prevedello, A. S. Raja, I. K. Ip, A. Sodickson, and 
R. Khorasani, "Does clinical decision support reduce 
unwarranted variation in Yield of CT pulmonary 
angiogram?," (in English), American Journal of 
Medicine, Article vol. 126, no. 11, pp. 975-981, 2013, 
doi: 10.1016/j.amjmed.2013.04.018. 
[6] T. Hodgson, A. Burton-Jones, R. Donovan, and C. 
Sullivan, "The role of EMRs in reducing unwarranted 
variation in acute health care processes: a systematic 
review," Under review, 2021. 
[7] G. R. Cohen, C. P. Friedman, A. M. Ryan, C. R. 
Richardson, and J. Adler-Milstein, "Variation in 
physicians’ electronic health record documentation and 
potential patient harm from that variation," Journal of 
general internal medicine, vol. 34, no. 11, pp. 2355-
2367, 2019. 
[8] M. J. Taylor, C. McNicholas, C. Nicolay, A. Darzi, D. 
Bell, and J. E. Reed, "Systematic review of the 
application of the plan–do–study–act method to 
improve quality in healthcare," BMJ quality & safety, 
vol. 23, no. 4, pp. 290-298, 2014. 
[9] Healthcare Quality Improvment Partnership, "Best 
practice in clinical audit," Healthcare Quality 
Improvement Partnership Ltd., 2020.  
[10] J. Thor et al., "Application of statistical process control 
in healthcare improvement: systematic review," (in 
eng), Qual Saf Health Care, vol. 16, no. 5, pp. 387-399, 
2007, doi: 10.1136/qshc.2006.022194. 
[11] P. Christoff, "Running PDSA cycles," Current 
problems in pediatric and adolescent health care, vol. 
48, no. 8, pp. 198-201, 2018. 
[12]  R. Wirth and J. Hipp, "CRISP-DM: Towards a standard 
process model for data mining," in Proceedings of the 
4th international conference on the practical 
applications of knowledge discovery and data mining, 
2000, vol. 1: Springer-Verlag London, UK.  
[13] G. D. Cleghorn and L. A. Headrick, "The PDSA Cycle 
at the Core of Learning in Health Professions 
Education," The Joint Commission Journal on Quality 
Improvement, vol. 22, no. 3, pp. 206-212, 1996/03/01/ 
1996, doi: https://doi.org/10.1016/S1070-
3241(16)30223-1. 
[14] W. A. Shewhart and W. E. Deming, Statistical method 
from the viewpoint of quality control. Courier 
Corporation, 1986. 
[15] W. E. Deming, Out of the Crisis. MIT press, 2018. 
[16] ACSQHC. "Healthcare Variation | Australian 
Commission on Safety and Quality in Health Care." 
Online. https://www.safetyandquality.gov.au/our-
work/healthcare-variation (accessed 26/11/2020. 
[17]  H. Asri, H. Mousannif, H. Al Moatassime, and T. Noel, 
"Big data in healthcare: challenges and opportunities," 
in 2015 International Conference on Cloud 
Technologies and Applications (CloudTech), 2015: 
IEEE, pp. 1-7.  
[18] T. J. Hannan, "Variation in health care—the roles of the 
electronic medical record," International Journal of 
Medical Informatics, vol. 54, no. 2, pp. 127-136, 1999. 
[19] U. Guo, L. Chen, and P. H. Mehta, "Electronic health 
record innovations: Helping physicians–One less click 
at a time," Health Information Management Journal, 
vol. 46, no. 3, pp. 140-144, 2017. 
[20] A. Duclos and N. Voirin, "The p-control chart: a tool 
for care improvement," International Journal for 
Quality in Health Care, vol. 22, no. 5, pp. 402-407, 
2010. 
[21] V. Cao et al., "Patient-centered structured 
interdisciplinary bedside rounds in the medical ICU," 
Critical care medicine, vol. 46, no. 1, pp. 85-92, 2018. 
[22] A. S. Detsky, "Regional variation in medical care," 
1995. 
[23] C. Castano, M. Love, R. Den Ouden, L. v. D. Neelen, 
Michael, and A. M. Giusto, "Working in Concert: A 
How-To Guide to Reducing Unwarranted Variation in 
Care."  
[24] K. K. Ganju, H. Atasoy, J. McCullough, and B. 
Greenwood, "The role of decision support systems in 
Page 3890
attenuating racial biases in healthcare delivery," 
Management Science, vol. 66, no. 11, pp. 5171-5181, 
2020. 
[25] M. A. Rosen et al., "Teamwork in healthcare: Key 
discoveries enabling safer, high-quality care," (in eng), 
Am Psychol, vol. 73, no. 4, pp. 433-450, May-Jun 2018, 
doi: 10.1037/amp0000298. 
[26] R. Al-Abri, "Managing change in healthcare," Oman 
medical journal, vol. 22, no. 3, p. 9, 2007. 
[27] L. H. Community, "Endorsers of the core values 
underlying a national‐scale person‐centered continuous 
Learning Health System (LHS)." 
[28] T. J. Foley and L. Vale, "What role for learning health 
systems in quality improvement within healthcare 
providers?," Learning Health Systems, vol. 1, no. 4, p. 
e10025, 2017. 
[29] C. P. Friedman and J. Macy Jr, "Toward complete & 
sustainable learning systems," University of Michigan, 
2014. 
[30] J. M. McGinnis, B. Powers, and C. Grossmann, "Digital 
infrastructure for the learning health system: the 
foundation for continuous improvement in health and 
health care: workshop series summary," 2011. 
[31] K. Walsh, "Managing a Budget in Healthcare 
Professional Education," (in eng), Ann Med Health Sci 
Res, vol. 6, no. 2, pp. 71-73, Mar-Apr 2016, doi: 
10.4103/2141-9248.181841. 
[32] M. J. Ott and G. H. Olsen, "Impact of quality 
assessment on clinical practice, Intermountain 
healthcare," in Quality Spine Care: Springer, 2019, pp. 
301-313. 
[33] T. K. Colicchio et al., "Looking behind the curtain: 
identifying factors contributing to changes on care 
outcomes during a large commercial EHR 
implementation," eGEMs, vol. 7, no. 1, 2019. 
 
Page 3891
